Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
4.
Nephrol Dial Transplant ; 9(12): 1747-50, 1994.
Article in English | MEDLINE | ID: mdl-7708258

ABSTRACT

We have observed that decreased plasma levels of C3 in the serum of three children with poststreptococcal acute glomerulonephritis (PSAGN) at the time of presentation were associated with the presence of C3NeF activity in purified serum IgG from the patients. C3NeF activity was determined using a sensitive assay measuring the ability of patients' IgG to stabilize a preformed cell-bound alternative pathway convertase complex. C3NeF activity of patients' IgG decreased within weeks as plasma levels of C3 progressively returned to normal values. C3NeF activity became undetectable within 1-4 months following normalization of plasma C3 levels. Our observations suggest that early alternative pathway-dependent hypocomplementaemia, a cardinal feature of PSAGN, is mediated by the transient expression of C3NeF autoantibody activity by patients' IgG.


Subject(s)
Complement C3 Nephritic Factor/analysis , Complement System Proteins/analysis , Glomerulonephritis/immunology , Immunoglobulin G/blood , Streptococcal Infections/immunology , Acute Disease , Child , Child, Preschool , Female , Humans , Male
5.
Ann Pediatr (Paris) ; 40(1): 41-3, 1993 Jan.
Article in French | MEDLINE | ID: mdl-8442645

ABSTRACT

A case of anorexia nervosa revealed by water intoxication with severe hyponatremia is reported after a search of the literature demonstrated the rarity of such cases. Pathophysiological mechanisms involved are discussed. Hospitalization in a unit for adolescents in which pediatricians and psychiatrists work together allowed both prompt treatment of metabolic disorders and early management of anorexia nervosa, which is associated with improved prognosis.


Subject(s)
Anorexia Nervosa/complications , Hyponatremia/etiology , Water Intoxication/etiology , Adolescent , Adolescent Psychiatry , Anorexia Nervosa/diagnosis , Anorexia Nervosa/therapy , Decision Trees , Diagnosis, Differential , Female , Hospitalization , Humans , Hyponatremia/diagnosis , Hyponatremia/therapy , Tomography, X-Ray Computed , Water Intoxication/diagnosis , Water Intoxication/therapy
6.
Ann Pediatr (Paris) ; 39(9): 543-9, 1992 Nov.
Article in French | MEDLINE | ID: mdl-1334393

ABSTRACT

From January 1, 1987 through December 31, 1990, twenty-four pediatric patients with human parvovirus B19 (HPV B19) infection were seen. In every case the diagnosis was established by a positive capture immunoassay for IgM antibodies against the HPV B19. Four patients had hematologic manifestations, including one case of transient bone marrow aplasia revealing hereditary spherocytosis, one case of autoimmune hemolytic anemia with beta-thalassemia, and two cases of peripheral thrombocytopenia. Eight patients had skin lesions, with a morbilliform rash in six cases, erythema nodosum in one case, and Gianotti-Crosti syndrome in one case. No patients had erythema infectiosum. Seven patients developed joint manifestations: Henoch-Schönlein purpura in two cases, arthralgia in four cases, and polyarticular disease progressing to severe rheumatoid arthritis in a thirteen-year-old girl. Unremarkable symptoms of viral disease were seen in three patients. A five-month-old infant developed severe acute myocarditis. One patient with hepatitis A had acute liver failure. This study confirms the broad spectrum of clinical manifestations of HPV B19 infection. There were a number of unusual findings, including the high rate of joint manifestations (29%) and the severe course of some hematologic and myocardial manifestations. These results raise the question of whether the HPV B19 may be involved in the genesis of chronic juvenile arthritis.


Subject(s)
Erythema Infectiosum/pathology , Parvoviridae Infections/diagnosis , Parvovirus B19, Human , Adolescent , Anemia, Aplastic/microbiology , Anemia, Hemolytic, Autoimmune/microbiology , Child , Erythroblasts , Female , Humans , IgA Vasculitis/microbiology , Infant , Joint Diseases/microbiology , Male , Neutropenia/microbiology , Purpura, Thrombocytopenic/microbiology , Retrospective Studies , Thrombocytopenia/microbiology
7.
Ann Pediatr (Paris) ; 38(9): 633-6, 1991 Nov.
Article in French | MEDLINE | ID: mdl-1750747

ABSTRACT

Fifty-six infants (aged 2 months to two years) with moderate to severe diarrhea were entered in a comparative therapeutic trial of smectite versus placebo or loperamide. Results showed that diarrhea resolved faster under smectite than under placebo and at least as fast under smectite as under loperamide. Tolerance of smectite is excellent as a result of the lack of any effect on intestinal motility.


Subject(s)
Diarrhea, Infantile/drug therapy , Gastrointestinal Agents/therapeutic use , Loperamide/therapeutic use , Silicates , Dehydration/prevention & control , Double-Blind Method , Drug Tolerance , Female , Humans , Infant , Male , Placebos , Time Factors , Weight Loss
SELECTION OF CITATIONS
SEARCH DETAIL
...